Dr Agarwals Healthcare IPO - Check IPO Date, Bid Price, Lot Size, Refund & Listing Date

About Dr Agarwals Healthcare:

They provide a comprehensive range of eye care services, including cataract, refractive, and other surgeries; consultations, diagnoses, and non-surgical treatments. Additionally, they offer optical products, contact lenses, accessories, and eye care-related pharmaceutical products. Their aim is to address all aspects of a patient’s eye treatment journey through a network that, as of September 30, 2024, consisted of 209 facilities.

About the Industry in which Dr Agarwals Healthcare operates:

According to the CRISIL MI&A Report, the eye care market in India experienced a compound annual growth rate (CAGR) of 11.5% between the financial years 2019 and 2024, reaching a value of ₹378 billion in the financial year 2024. This market encompasses both surgical and non-surgical treatments for various eye disorders. Surgical treatments include cataract surgery, glaucoma procedures, retina surgeries, refractive surgeries, corneal surgeries, and other eye-related operations, with cataract surgery holding the largest share in the surgical segment. Non-surgical treatments cover general check-ups, pre-treatment assessments, post-treatment follow-ups, diagnostics, and related services.

Important Information and Timelines of the IPO of Dr Agarwals Healthcare:
Open Date 29 January 2025
Close Date 31 January 2025
Total Issue Size – Number of Shares 75304970
Minimum Bid Price 382
Maximum Bid Price 402
Lot Size 35
Basis of Allotment 3 February 2025
Initiation of Refunds and Credit of Shares to Demat 4 February 2025
Listing Date 5 February 2025
Listing Exchange(s) NSE and BSE

Minimum and Maximum Lot Sizes for the IPO of Dr Agarwals Healthcare:

Category Lots Shares Amount (in ₹)
Retail – Minimum 1 35 14070
Retail – Maximum 14 490 196980
sHNI – Minimum 15 525 211050
sHNI – Maximum 71 2485 998970
bHNI – Minimum 72 2520 1013040

Objective of the IPO of Dr Agarwals Healthcare:

  1. Repayment or prepayment (in part or full) of certain borrowings

  2. General corporate purposes

  3. Potential unidentified inorganic acquisitions

Financials of Dr Agarwals Healthcare:

Particulars As at and for the six months ended September 30, 2024 As at and for the six months ended September 30, 2023 As at and for the Financial Year ended March 31, 2024 As at and for the Financial Year ended March 31, 2023 As at and for the Financial Year ended March 31, 2022
Equity Share Capital 307.56 93.25 93.29 79.26 68.60
Instruments in the Nature of Equity - 0.31 0.31 - -
Other Equity 14,736.35 12,793.01 13,300.48 6,216.31 2,055.17
Net Worth 15,026.67 12,869.33 13,376.84 6,278.33 2,123.37
Total Income 8,379.40 6,626.90 13,764.49 10,314.94 7,137.84
Revenue from Operations 8,200.63 6,505.75 13,321.52 10,179.80 6,960.78
Restated Profit for the Period/Year 395.64 311.33 950.51 1,032.30 431.64
Earnings Per Share (Basic) 1.00 0.98 3.14 4.01 1.83
Earnings Per Share (Diluted) 1.00 0.98 3.13 4.00 1.83
Net Asset Value Per Equity Share 52.72 51.54 50.53 26.73 10.32
Total Borrowings 3,736.82 3,946.90 3,877.87 3,561.77 2,901.80

For more details on the IPO, refer to the DRHP here.

Did you know that you can now Pre-Apply for an IPO on Dhan? You can place your IPO Bid on Dhan and the order will be pushed to the Exchange as soon as the Bidding starts for Dr Agarwals Healthcare. You will receive a UPI mandate after 10:00 AM on 29 January 2025.

###1. How to apply for the IPO of Dr Agarwals Healthcare on Dhan?
You can apply for the IPO of Dr Agarwals Healthcare from either Dhan Mobile App or Web
On Dhan Mobile App you can find the IPO under the Money Section > IPO Tab
On Dhan Web you can find the IPO under Markets Tab > IPOs

###2. In case of successful allotment, when the IPO shares of Dr Agarwals Healthcare be visible on Dhan?
The CDSL will intimate you regarding the credit of shares into your Demat account by 4 February 2025. However, you will be able to see the shares of Dr Agarwals Healthcare on Dhan before the market starts on the listing date which is 5 February 2025.